Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05903521 · ClinicalTrials.gov registry record
BAriatric Surgery Induced Chromosomal Change
A clinical trial, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- 120
- Enrollment target
NCT05903521 is a clinical trial that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 120 participants.
The verdict
NCT05903521 was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- 120 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand the impact of weight-loss surgery on telomere length. Telomeres are a key marker of biological aging of cells. Telomere shortening is a natural process of aging. Several pathologies and lifestyles are associated with premature telomere shortening, such as obesity, diabetes mellitus or sedentary lifestyle. New evidence supports that telomere shortening can be partially reversed by lifestyle changes such as healthy diet, reduced stress, or increased physical activity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-06-12 |
| Est. Completion | 2025-01-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05903521
The ClinicalTrials.gov registry entry for NCT05903521 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05903521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05903521 about?
NCT05903521 is a clinical study titled "BAriatric Surgery Induced Chromosomal Change". The purpose of this study is to better understand the impact of weight-loss surgery on telomere length. Telomeres are a key marker of biological aging of cells. Telomere shortening is a natural process of aging. Several pathologies and lifestyles are associated with premature telomere shortening, su...
What is the current status of trial NCT05903521?
This trial is currently terminated. The enrollment target is 120 participants. The study started on 2023-06-12. Estimated completion is 2025-01-20.
Who is sponsoring clinical trial NCT05903521?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.